Defining Blood-induced Microglia Functions in Neurodegeneration Through Multiomic Profiling
Overview
Authors
Affiliations
Blood protein extravasation through a disrupted blood-brain barrier and innate immune activation are hallmarks of neurological diseases and emerging therapeutic targets. However, how blood proteins polarize innate immune cells remains largely unknown. Here, we established an unbiased blood-innate immunity multiomic and genetic loss-of-function pipeline to define the transcriptome and global phosphoproteome of blood-induced innate immune polarization and its role in microglia neurotoxicity. Blood induced widespread microglial transcriptional changes, including changes involving oxidative stress and neurodegenerative genes. Comparative functional multiomics showed that blood proteins induce distinct receptor-mediated transcriptional programs in microglia and macrophages, such as redox, type I interferon and lymphocyte recruitment. Deletion of the blood coagulation factor fibrinogen largely reversed blood-induced microglia neurodegenerative signatures. Genetic elimination of the fibrinogen-binding motif to CD11b in Alzheimer's disease mice reduced microglial lipid metabolism and neurodegenerative signatures that were shared with autoimmune-driven neuroinflammation in multiple sclerosis mice. Our data provide an interactive resource for investigation of the immunology of blood proteins that could support therapeutic targeting of microglia activation by immune and vascular signals.
Glycocalyx dysregulation impairs blood-brain barrier in ageing and disease.
Shi S, Suh R, Shon D, Garcia F, Buff J, Atkins M Nature. 2025; .
PMID: 40011765 DOI: 10.1038/s41586-025-08589-9.
Endothelial-Ercc1 DNA repair deficiency provokes blood-brain barrier dysfunction.
Hansen C, Vacondio D, van der Molen L, Juttner A, Fung W, Karsten M Cell Death Dis. 2025; 16(1):1.
PMID: 39753531 PMC: 11698980. DOI: 10.1038/s41419-024-07306-0.
Multiple Sclerosis: Glial Cell Diversity in Time and Space.
Kooistra S, Schirmer L Glia. 2024; 73(3):574-590.
PMID: 39719685 PMC: 11784844. DOI: 10.1002/glia.24655.
Neuroinflammation in Alzheimer disease.
Heneka M, van der Flier W, Jessen F, Hoozemanns J, Thal D, Boche D Nat Rev Immunol. 2024; .
PMID: 39653749 DOI: 10.1038/s41577-024-01104-7.
First-in-human Evaluation of Safety and Dosimetry of [Cu]FBP8: A fibrin-binding PET Probe.
Izquierdo-Garcia D, Desogere P, Philip A, Sosnovik D, Catana C, Caravan P Mol Imaging Biol. 2024; 27(1):99-108.
PMID: 39633070 DOI: 10.1007/s11307-024-01973-3.